Mandate

Vinge advises Jarðvarmi och Ancala Partners in connection with the acquisition of Magma Energy Sweden AB and HS Orka

June 13, 2019 M&A

Vinge has advised Jarðvarmi slhf., a consortium of 14 Icelandic pension funds, and Ancala Partners’ mid-market focused infrastructure fund Ancala Infrastructure Fund II in questions regarding Swedish law in connection with the acquisition of Magma Energy Sweden AB and its subsidiary HS Orka, Iceland’s largest private electricity generator.

In connection with the transaction, Jarðvarmi exercised its right of first refusal to acquire a 53.9% interest in HS Orka from Alterra Power Corp, a subsidiary of Innergex Renewable Energy Inc. Jarðvarmi has also agreed to acquire a 12.7% interest in HS Orka from Fagfjárfestasjóðurinn ORK. The remaining 33.4% in HS Orka was already owned by Jarðvarmi. Following the transactions Ancala Partners and Jarðvarmi will each own 50% of HS Orka.

The purchase price for the acquisition of Alterra’s 53.9% interest was USD 299.9 million. The purchase price for the acquisition of Fagfjárfestasjóðurinn ORK’s 12.7% interest was not disclosed. 

Ancala Partners and Jarðvarmi have further agreed to divest HS Orka’s 30% interest in the Blue Lagoon, Iceland’s leading tourist attraction, to Blávarmi. The sale transitions HS Orka into a pure play renewable energy platform. HS Orka has been producing renewable energy for 40 years and operates two geothermal powerplants, Svartsengi and Reykjanes, as well as a hydro powerplant at Bláskógabyggð.

The Vinge team consisted of partner Peter Sundgren and associate Christina Odengran. Counsel Maria Schultzberg advised in tax matters. 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025